Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7685387> ?p ?o }
Showing triples 1 to 48 of
48
with 100 triples per page.
- Q7685387 subject Q7071513.
- Q7685387 subject Q7335370.
- Q7685387 subject Q8248726.
- Q7685387 subject Q8334258.
- Q7685387 subject Q8341873.
- Q7685387 subject Q8879081.
- Q7685387 subject Q8919936.
- Q7685387 subject Q9052323.
- Q7685387 abstract "Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist that was investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co.In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects, mainly depression and anxiety.".
- Q7685387 atcPrefix "A08".
- Q7685387 atcSuffix "AX".
- Q7685387 casNumber "701977-09-5".
- Q7685387 fdaUniiCode "X9U622S114".
- Q7685387 iupacName "N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)-2-butanyl]-2-methyl-2-{[5-(trifluoromethyl)-2-pyridinyl]oxy}propanamide".
- Q7685387 pubchem "11226090".
- Q7685387 thumbnail Taranabant.png?width=300.
- Q7685387 wikiPageWikiLink Q12174.
- Q7685387 wikiPageWikiLink Q154430.
- Q7685387 wikiPageWikiLink Q1671731.
- Q7685387 wikiPageWikiLink Q21163314.
- Q7685387 wikiPageWikiLink Q247489.
- Q7685387 wikiPageWikiLink Q30612.
- Q7685387 wikiPageWikiLink Q4340209.
- Q7685387 wikiPageWikiLink Q47273.
- Q7685387 wikiPageWikiLink Q5032579.
- Q7685387 wikiPageWikiLink Q567709.
- Q7685387 wikiPageWikiLink Q7071513.
- Q7685387 wikiPageWikiLink Q7335370.
- Q7685387 wikiPageWikiLink Q8248726.
- Q7685387 wikiPageWikiLink Q8334258.
- Q7685387 wikiPageWikiLink Q8341873.
- Q7685387 wikiPageWikiLink Q8879081.
- Q7685387 wikiPageWikiLink Q8919936.
- Q7685387 wikiPageWikiLink Q9052323.
- Q7685387 atcPrefix "A08".
- Q7685387 atcSuffix "AX".
- Q7685387 casNumber "701977".
- Q7685387 iupacName "N-[-4--3--2-butanyl]-2-methyl-2-{[5--2-pyridinyl]oxy}propanamide".
- Q7685387 pubchem "11226090".
- Q7685387 unii "X9U622S114".
- Q7685387 type ChemicalSubstance.
- Q7685387 type Drug.
- Q7685387 type ChemicalObject.
- Q7685387 type Thing.
- Q7685387 type Q8386.
- Q7685387 comment "Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist that was investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co.In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects, mainly depression and anxiety.".
- Q7685387 label "Taranabant".
- Q7685387 depiction Taranabant.png.